← Leaderboards
Lauren M Jansson
Johns Hopkins University
$8,360,007
Attributed
$8,360,007
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $624.8K · FY2005–22$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$8,360,007 · 4
By mechanism
R01$7,563,776 · 3
K08$796,231 · 1
Top collaborators
No co-investigators on record.
Most similar at Johns Hopkins University
Same institution · by research overlap
- Hendree E. Jones$34,132,831
- Jay B Jackson$35,788,379
- Janet A. Di Pietro$7,150,199
- Rupak Shivakoti$5,705,971
- Valerie Lynn Baker$5,126,486
Others in their field
Top investigators on “Methadone”
- Sharon L. Walsh · University Of Kentucky$87,877,483
- Edward V Nunes · Columbia University Health Sciences$35,485,258
- Marco Pravetoni · Hennepin Healthcare Research Institute$33,709,846
- Walter Nmn Ling · University Of California Los Angeles$31,920,766
- Frederick Lewis Altice · Yale University$26,048,732
- Abhik Das · Research Triangle Institute$25,628,714
Research focus
MethadoneBuprenorphineNeurobehaviorNeurobehavioralPregnancySeveritiesPhysiologicalFetusPregnant WomenOpioidInfantNeonatal Abstinence SyndromeFetalWomanPregnantClinical ResearchNewborn InfantAge-MonthsBirthCohortMaintenanceMothersNeonatePharmaceutical Preparations
Grant awards (23)
Maternal buprenorphine-naloxone treatment during the perinatal period: Fetal and infant effects$582,867
R01 · FY2022 · DA · contact PI
Maternal buprenorphine-naloxone treatment during the perinatal period: Fetal and infant effects$582,867
R01 · FY2021 · DA · contact PI
Maternal buprenorphine-naloxone treatment during the perinatal period: Fetal and infant effects$582,867
R01 · FY2020 · DA · contact PI
Maternal buprenorphine-naloxone treatment during the perinatal period: Fetal and infant effects$585,731
R01 · FY2019 · DA · contact PI
Maternal buprenorphine-naloxone treatment during the perinatal period: Fetal and infant effects$624,774
R01 · FY2017 · DA · contact PI
Fetal and Infant Neurobehavioral Effects of maternal Buprenorphine Treatment$496,260
R01 · FY2015 · DA · contact PI
Fetal and Infant Neurobehavioral Effects of maternal Buprenorphine Treatment$499,354
R01 · FY2014 · DA · contact PI
Fetal and Infant Neurobehavioral Effects of Maternal Buprenorphine Treatment$85,105
R01 · FY2014 · DA · contact PI
Fetal and Infant Neurobehavioral Effects of maternal Buprenorphine Treatment$474,420
R01 · FY2013 · DA · contact PI
Fetal and Infant Neurobehavioral Effects of maternal Buprenorphine Treatment$93,022
R01 · FY2013 · DA · contact PI
Fetal and Infant Neurobehavioral Effects of maternal Buprenorphine Treatment$494,202
R01 · FY2012 · DA · contact PI
Fetal and Infant Neurobehavioral Effects of maternal Buprenorphine Treatment$514,140
R01 · FY2011 · DA · contact PI
Fetal and Infant Neurobehavior in Opiate Dependent Women$399,141
R01 · FY2009 · DA · contact PI
Fetal and Infant Neurobehavior in Opiate Dependent Women$384,377
R01 · FY2008 · DA · contact PI
Fetal and Infant Neurobehavior in Opiate Dependent Women$381,135
R01 · FY2007 · DA · contact PI
Fetal and Infant Neurobehavior in Opiate Dependent Women$381,428
R01 · FY2006 · DA · contact PI
Fetal and Infant Neurobehavior in Opiate Dependent Women$402,086
R01 · FY2005 · DA
METHADONE, BUPRENORPHINE AND FETAL DEVELOPMENT$163,567
K08 · FY2004 · DA
METHADONE, BUPRENORPHINE AND FETAL DEVELOPMENT$160,551
K08 · FY2003 · DA
METHADONE, BUPRENORPHINE AND FETAL DEVELOPMENT$157,618
K08 · FY2002 · DA
METHADONE, BUPRENORPHINE AND FETAL DEVELOPMENT$4,578
K08 · FY2002 · DA
METHADONE, BUPRENORPHINE AND FETAL DEVELOPMENT$154,766
K08 · FY2001 · DA
METHADONE, BUPRENORPHINE AND FETAL DEVELOPMENT$155,151
K08 · FY2000 · DA